Acadia Pharmaceuticals buy Bank of America Co.
Start price
25.03.26
/
50%
€19.04
Target price
25.03.27
€24.99
Performance (%)
19.43%
Price
19:29
€22.74
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 19.43%. This prediction currently runs until 25.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.684% | 1.684% |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.15
30.06.26
30.06.26
€26.32
30.06.27
30.06.27
2.66%
19:29
19:29
